期刊文献+

乙肝相关性原发性肝癌预后因素分析及抗病毒治疗预后观察 被引量:4

下载PDF
导出
摘要 目的探讨乙肝相关性原发性肝癌预后因素分析及抗病毒治疗预后。方法选取研究对象为160例乙肝相关性原发性肝癌患者,选取时间为2008年1月至2013年2月,均实施无水酒精注射疗法、射频消融、根治切除法及抗病毒治疗,且对治疗后影响预后因素进行观察及分析。结果经单因素分析影响预后主要因素在于HCC分期、肿瘤数目、肿瘤数目、糖尿病;而进行多因素分析影响预后因素在于HBe阳性抗原。结论 HBe阳性抗原能够对乙肝相关性原发性肝癌患者的预后造成直接影响,因此临床上实施抗病毒治疗尤为重要,有利于改善患者的预后及生命质量。
出处 《现代医学与健康研究电子杂志》 2018年第15期63-64,共2页 Modern Medicine and Health Research
  • 相关文献

参考文献4

二级参考文献42

  • 1杨磊,倪润洲,肖明兵,华国平,陆翠华,黄介飞.HS-AFP对原发性肝癌病情及手术预后判断的价值[J].江苏医药,2006,32(10):906-908. 被引量:6
  • 2Taniai N, Yoshida H, Yoshioka M, et al. Surgical outcomes and prognostic factors in elderly patients (75 years or older) with hepatocellular carcinoma who underwent hepatectomy[J]. J Nippon Med Sch,2013,80(6) :426-432.
  • 3Tanaka S, Kitamura T, Fujita M, et al. Color Doppler flow imaging of liver tumors[J]. Am J Roentgenol, 1990, 154 (3): 509-514.
  • 4Radu P, Groza I, Iancu C, et al. Treatment of hepatocellular carcinoma in a tertiary Romanian center. Deviations from BCLC recommendations and influence on survival rate [J]. J Gastrointestin Liver Dis, 2013,22(3) : 291-297.
  • 5Chang WC, Chen RC, Chou CT, et al. Histological grade of hepatocellular carcinoma correlates with arterial enhancement on gadoxetic acid enhanced and diffusion-weighted MR images[J]. Abdom Imaging, 2014,39(6) : 1202-1212.
  • 6Zhan P, Qian Q, Yu LK. Prognostic significance of vascular endothelial growth factor expression in hepatocellular carcinoma tissue: a meta-analysis[J]. Hepatobiliary Surg Nutr, 2013, 2 (3): 148-156.
  • 7Nishikawa H, Inuzuka T, Takeda H, et al. A case of advanced hepa- tocellular carcinoma with portal vein tumor thrombus refractory" to epi-rubicin that showed nmrked decrease in tumor markers after transeath- eter arterial infusion with miriplatin [ J ]. Case Rep Oncol, 2011, 4 (2) : 327-335.
  • 8Villa E, Moles A, Ferretti I, et al. Natural history of inoperable hep- atoeellular carcinoma: Estrogen receptors' status in the tumor is the strongest prognostic factor for survival [ J ]. Hepatology, 2000, 32 (2) : 233-238. DOI : 10. 1053/jhep. 2000. 9603.
  • 9Tawada A, Chiba T, Ooka Y, et al. Efficacy of transarterial chemo- embolization targeting portal vein tumor thrombus in patients with hep- atocellular carcinoma [ J]. Anticaneer Res, 2014, 34 ( 8 ) : 4231- 4237.
  • 10Shi J, Lai EC, Li N, et al. A new classification for hepatocellular carcinoma with portal vein tumor thrombus [ J ]. J Hepatobiliary Pan- creat Sci, 2011, 18( 1 ) : 74-80. DOI: 10. 1007/s005344310-0314- 0.

共引文献28

同被引文献69

引证文献4

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部